Answers are grounded in this paper and cite their sources.
Integrative methods enhance antifungal activity in Jatropha curcas ethosomal gel, suggesting potential for herbal therapy.
Introduction: In order to create an ethosomal gel based on Jatropha curcas that has improved antifungal activity, this study combines Quality by Design (QbD), computational modeling, and phytochemical profiling. Method: GC–MS analysis of the methanolic seed extract identified key bioactives, including NHexadecanoic acid, 9,12-Octadecadienoic acid (Z, Z), and (Z)6, (Z)9-Pentadecadien-1-ol, which exhibited strong binding affinities toward fungal CYP51 (PDB ID: 5TZ1) in molecular docking and favorable ADMET properties. Results: A Central Composite Design was used to optimize the formulation parameters (lipid concentration, ethanol content, and sonication time), resulting in ethosomes with a particle size of 154.1 ± 0.81 nm, a zeta potential of −29.6 ± 0.21 mV, and a high entrapment efficiency. Discussion: The optimized gel demonstrated sustained drug release (97 ± 0.68%) following Higuchi kinetics and superior in vitro antifungal activity against Candida albicans, Microsporum canis, and M. audouinii compared to the crude extract gel. Conclusion: Overall, the findings establish J. curcas ethosomal gel as a promising topical antifungal formulation and demonstrate the value of integrating QbD and in silico tools in herbal drug development.
No takes yet. Share an insight, caveat, or question.
Damani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: